News Release

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

Grant and Award Announcement

Aligning Science Across Parkinson's

The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for research community members to apply for funding to develop novel tools to advance Parkinson’s disease (PD) research. The Collaborative Research Network (CRN) 2025 Technical Track grants will support the development of sustainable tools to accelerate validation and therapeutic research and discovery for emerging targets identified through ASAP discoveries, offering funding of up to $2M per year over three years, up to $6M total.

"By bringing researchers together to generate new preclinical tools for targets studied in our ASAP programs, our goal is to help accelerate discovery and research outcomes for Parkinson’s disease,” said Sonya Dumanis, PhD, deputy director of ASAP. “This funding opportunity builds on the Collaborative Research Network's collective efforts to grow our understanding of Parkinson’s disease through collaboration, resource generation, and data sharing."

Projects supported within the Technical Track will consist of three key components: tool generation, validation, and distribution for at least five eligible targets identified through ASAP discoveries. In addition, teams must adhere to the ASAP team composition, application, and budgetary guidelines while committing to follow ASAP’s Open Science Policy. Letter of Intent submissions are due on May 5, 2025, at 6pm ET. ASAP will announce funding decisions in February 2026.

Tools for emerging targets could include the following areas of focus: 

  • Generation of preclinical models to support in vivo or in vitro assessments of targets of interest

  • Generation of detection reagents such as antibodies, nanobodies, or probes to support improved measurement or visualization of the target or target activity

  • Generation of modulation agents such as viral vectors, compounds, or antisense oligonucleotides to understand the directionality of therapeutic benefit for PD

Teams within the Technical Track will join the ASAP CRN, an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority research questions. 

Learn more about the funding opportunity, access the Letter of Intent (LOI) instructions, and view all requirements by visiting https://parkinsonsroadmap.org/funding-opportunities/technical-track/# 

About 

Aligning Science Across Parkinson’s is a research initiative comprised of international, multidisciplinary, and multi-institutional researchers working to address resource and knowledge gaps in the development and progression of Parkinson’s disease.​ ASAP is deeply rooted in the belief that we can accelerate advances by fostering a collaborative and open approach to research. ASAP is managed by the Coalition for Aligning Science and is working with The Michael J. Fox Foundation to implement its programs. For more information, visit our website and connect with us on LinkedIn and Bluesky

Contact:

Rosanna Vierra, GMMB

rosanna.vierra@gmmb.com 

808.215.1173


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.